Lenzing Tightens the Screws: Value Over Volume, Cost Pass-Through, and a New Strategy
A Resilient First Half
Lenzing's Q2 2026 results demonstrated a clear ability to hold its ground even as input costs spiked. Revenue was 'only modestly lower' year-on-year despite a 'particularly strong' H1 2025 comparison base, as the company deliberately pruned low-margin volumes. The headline from CEO Georg Kasperkovitz was 'strengthened resilience.' “The takeaway for you is simple, a robust first half that keeps us firmly on track and a strong platform from which” — Georg Kasperkovitz, CEO · 2026-08-05 the new strategy can be executed. The Middle East conflict has been a key driver of cost inflation, but management stressed the impact was on costs, not demand, with customers proving resilient.
CFO Mathias Breuer highlighted that 'operational EBITDA is clearly above the EUR 100 million run rate' after stripping out one-offs such as CO2 certificate sales and bio-asset valuation gains. That is a significant milestone for a company that has been rebuilding profitability after years of overcapacity and weak pricing.
Cost Pass-Through and Pricing Power
The ability to pass through higher costs was central to the quarter. “We use the cost increases to adjust the overall pricing level,... The order intake remains robust” — Mathias Breuer, CFO · 2026-08-05 said Breuer. Notably, caustic soda spend runs 'slightly above EUR 10 million per month' across four production sites, and sulfur costs have risen threefold year-to-date. Yet management maintained that 'we are able to defend the current price level' in fiber products, as global fiber prices have moved up alongside competing materials like cotton and polyester.
This pricing discipline is reinforced by a value over volume approach. Volumes remained broadly stable in Q2, but selling prices rose ~6% in both USD and EUR. The company is 'running on full capacity' and 'whatever we produce is currently being sold out,' which points to a tight market. The Caustic soda and energy cost headwinds are expected to persist, but management's weekly structured monitoring and cost-pass-through mechanisms provide a buffer.
The New Strategy: From Survival to Focus
Just a week before the call, Lenzing unveiled a new strategy with clear mid-term targets: an EBITDA uplift of approximately EUR 150 million, an EBITDA margin of 20%–25%, and leverage below 2.5x. “Everything we are executing, the cost program, capital efficiency measures, and continued innovation is geared towards delivering these midterm targets.” — Mathias Breuer, CFO · 2026-08-05 The strategy centers on two levers: growing nonwovens and resetting the fiber textile business, while achieving a more balanced portfolio and leaner cost base. This is a departure from the previous 'performance program,' which was more internally focused; the new new strategy explicitly aims at portfolio reshaping.
Management was candid that cost measures are already underway—'around EUR 25 million of the EUR 120 million program... are already fully in the books.' The shift toward high-value segments like nonwovens and specialty fibers is reflected in the continued premiumization of the product mix.
From Tariffs to Conflict: A Shifting Narrative
Prior quarters were dominated by tariff uncertainty and its impact on demand. In August 2025, CEO Rohit Aggarwal described how the tariff shock led to a 'big change in quarter 2... April to be a bit of a kind of a drop significantly.' “The big change in quarter 2 because of tariff situation and uncertainty led April to be a bit of a kind of a drop significantly.” — Rohit Aggarwal, Chief Executive Officer · 2025-08-08 This quarter, the narrative has shifted to supply-side cost pressures from the Middle East conflict, with demand remaining robust. The company's ability to adapt its commercial strategy—appointing a new, more effective sales organization and actively managing customer relationships—has been key.
The resilience story is also visible in the balance sheet. Net debt declined year-on-year, and trade working capital improved to 17.6% of revenue. While leverage ticked up to 3.6x EBITDA on a trailing basis (due to weaker H2 2025), the company reaffirmed its commitment to reducing leverage over time.
For investors, Lenzing's call signals a company that is no longer merely surviving but positioning itself for a more profitable future. The cost pass-through ability, combined with a clear capital allocation framework and execution focus, suggests that the EUR 150 million EBITDA uplift is not just aspiration but the product of ongoing self-help measures. The global context is supportive: competing fiber prices are elevated, and the structural shift toward cellulosic fibers remains intact. As management summed up,
We remain laser-focused on delivering the new strategy. That is the management team's single largest priority.